Pharmacodynamics study performed by estimating the transcript levels of Rac1, Cdc42, HIF-1α, β-catenin and DDX3 in the tumor tissue reveled a significant downregulation of these important metastasis markers in the combination group as compared to the drug alone group (Fig. 7E). The gene discussed is RAC1; the disease is neoplasm.